Clinical trial
Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary…
NCT00003418 · International Collaborative Cancer Group, Other · Unknown status
Key facts
| NCT number | NCT00003418 |
|---|---|
| Title | Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer |
| Official title | Randomized Double-Blind Trial in Postmenopausal Women With Primary Breast Cancer Who Have Received Adjuvant Tamoxifen for 2-3 Years, Comparing Subsequent Adjuvant Exemestane Treatment With Further Tamoxifen |
| Lead sponsor | International Collaborative Cancer Group, Other |
| Collaborators | European Organisation for Research and Treatment of Cancer - EORTC UNICANCER |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | exemestane, tamoxifen citrate |
| Enrollment | 4,400 |
| Start date | Feb 1, 1998 |
| First posted | Jan 23, 2004 |
| Last update posted | Dec 19, 2013 |
| Countries | Belgium, France, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: